Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Nociception and Migraine

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 4, 2015-05 ,pp. : 540-553

Bentham Science Publishers

Access to resources Recommend Favorite

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis

By  

Current Pharmaceutical Design, Vol. 17, Iss. 3, 2011-01 ,pp. : 204-214

Bentham Science Publishers

Access to resources Recommend Favorite

The Secretin/Pituitary Adenylate Cyclase-Activating Polypeptide/ Vasoactive Intestinal Polypeptide Superfamily in the Central Nervous System

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 1, 2006-03 ,pp. : 27-57

Bentham Science Publishers

Access to resources Recommend Favorite

The effects of pituitary adenylate cyclase-activating polypeptide on cerebral arteries and vertebral artery blood flow in anesthetized dogs

By Seki Y.   Suzuki Y.   Baskaya M.K.   Kano T.   Saito K.   Takayasu M.   Shibuya M.   Sugita K.  

European Journal of Pharmacology, Vol. 275, Iss. 3, 1995-03 ,pp. : 259-266

Elsevier

Access to resources Recommend Favorite

Regional differences in cardiac effects of pituitary adenylate cyclase-activating polypeptide-27 in the isolated dog heart

By Hirose M.   Furukawa Y.   Lakhe M.   Chiba S.  

European Journal of Pharmacology, Vol. 349, Iss. 2, 1998-05 ,pp. : 269-276

Elsevier

Access to resources Recommend Favorite